Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,800 | 828 | 99.7% |
| Education | $32.49 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,217 | 160 | $0 (2024) |
| PFIZER INC. | $1,586 | 114 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,358 | 91 | $0 (2024) |
| Lilly USA, LLC | $1,126 | 75 | $0 (2024) |
| GlaxoSmithKline, LLC. | $921.57 | 67 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $646.45 | 42 | $0 (2023) |
| Amgen Inc. | $548.82 | 44 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $426.99 | 36 | $0 (2023) |
| ABBVIE INC. | $418.97 | 36 | $0 (2024) |
| Amarin Pharma Inc. | $363.00 | 23 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $974.58 | 52 | Lilly USA, LLC ($215.29) |
| 2023 | $1,096 | 69 | Lilly USA, LLC ($222.07) |
| 2022 | $1,197 | 74 | Lilly USA, LLC ($255.02) |
| 2021 | $1,423 | 106 | Novo Nordisk Inc ($258.22) |
| 2020 | $1,797 | 122 | Novo Nordisk Inc ($356.15) |
| 2019 | $1,550 | 119 | Novo Nordisk Inc ($366.82) |
| 2018 | $1,863 | 135 | Novo Nordisk Inc ($461.42) |
| 2017 | $1,932 | 156 | Novo Nordisk Inc ($465.43) |
All Payment Transactions
833 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Oncology | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/19/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: UROLOGY | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Bausch Health US, LLC | WELLBUTRIN (Drug) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Neurology | ||||||
| 10/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Obesity | ||||||
| 09/24/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: Hematology | ||||||
| 09/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $7.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/10/2024 | Bausch Health US, LLC | WELLBUTRIN (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Neurology | ||||||
| 08/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: RESPIRATORY | ||||||
| 08/20/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Oncology | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Cardio-renal | ||||||
| 08/05/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: Diabetes | ||||||
| 07/24/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Hematology | ||||||
| 07/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,271 | 2,702 | $231,643 | $92,778 |
| 2022 | 21 | 1,141 | 2,190 | $214,590 | $93,185 |
| 2021 | 23 | 1,385 | 2,496 | $221,716 | $102,245 |
| 2020 | 19 | 1,113 | 1,944 | $193,879 | $78,922 |
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 272 | 707 | $120,270 | $47,796 | 39.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 116 | 214 | $25,680 | $10,686 | 41.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 47 | 58 | $13,380 | $6,120 | 45.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 38 | 38 | $9,500 | $5,288 | 55.7% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 126 | 126 | $7,686 | $4,220 | 54.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 125 | 125 | $5,625 | $3,563 | 63.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 15 | 18 | $5,760 | $3,163 | 54.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 29 | 29 | $5,330 | $3,147 | 59.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 49 | 49 | $5,880 | $2,644 | 45.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 95 | 242 | $13,310 | $1,883 | 14.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 17 | 20 | $2,780 | $709.84 | 25.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 15 | 19 | $2,280 | $660.25 | 29.0% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 13 | 26 | $2,080 | $655.20 | 31.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 13 | 16 | $1,600 | $597.78 | 37.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 24 | 26 | $1,950 | $528.72 | 27.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 35 | 38 | $2,280 | $329.50 | 14.5% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 29 | 29 | $435.00 | $177.19 | 40.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 19 | 19 | $950.00 | $177.07 | 18.6% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 29 | 29 | $1,160 | $147.32 | 12.7% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 33 | 41 | $820.00 | $127.51 | 15.6% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 39 | 253 | $1,265 | $83.69 | 6.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 82 | 544 | $1,082 | $44.22 | 4.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 11 | 36 | $540.00 | $31.06 | 5.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 272 | 666 | $113,220 | $49,154 | 43.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 75 | 97 | $22,210 | $11,047 | 49.7% |
About Dr. David Bachofer, MD
Dr. David Bachofer, MD is a Internal Medicine healthcare provider based in Florence, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316058100.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Bachofer, MD has received a total of $11,832 in payments from pharmaceutical and medical device companies, with $974.58 received in 2024. These payments were reported across 833 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($11,800).
As a Medicare-enrolled provider, Bachofer has provided services to 4,910 Medicare beneficiaries, totaling 9,332 services with total Medicare billing of $367,130. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Florence, AL
- Active Since 08/31/2006
- Last Updated 12/28/2009
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1316058100
Products in Payments
- FARXIGA (Drug) $1,203
- Ozempic (Drug) $981.45
- TRELEGY ELLIPTA (Drug) $607.14
- MOUNJARO (Drug) $599.06
- JARDIANCE (Drug) $543.33
- CHANTIX (Drug) $513.37
- ELIQUIS (Drug) $434.51
- Tresiba (Drug) $393.71
- XARELTO (Drug) $385.39
- Vascepa (Drug) $363.00
- TRULICITY (Drug) $349.34
- Kerendia (Drug) $333.31
- Saxenda (Drug) $299.18
- Victoza (Drug) $287.45
- VRAYLAR (Drug) $272.83
- LYRICA (Drug) $269.70
- EVENITY (Biological) $181.18
- ACCRUFER (Drug) $168.12
- Wegovy (Drug) $161.59
- VIAGRA (Drug) $151.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Florence
Cyrus Kocherla, Md, MD
Internal Medicine — Payments: $113,901
Dr. Subir Paul, M.d, M.D
Internal Medicine — Payments: $75,565
Dr. John Patton, Md, MD
Internal Medicine — Payments: $47,520
Dr. Rishika Motiani, M.d, M.D
Internal Medicine — Payments: $45,711
Davinderbir Pannu, Md, MD
Internal Medicine — Payments: $43,684
Dr. Justin Case, Md, MD
Internal Medicine — Payments: $23,099